Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues
- 18 April 2005
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 24 (17) , 2787-2795
- https://doi.org/10.1038/sj.onc.1208611
Abstract
P21 and p16, first identified as two small molecular weight proteins in CDK and cyclin immunocomplexes, represent two distinct families constituting a total of seven CDK inhibitors in mammalian cells. The physiological functions of these genes are believed to be broadly involved in connecting various cellular pathways to cell cycle control. Extensive studies over the past 10 years have led to a fairly clear understanding of their biochemical and cellular mechanisms and have also left some unresolved and controversial issues.Keywords
This publication has 124 references indexed in Scilit:
- Regulation of the Human Cyclin-dependent Kinase Inhibitor p18 by the Transcription Factors E2F1 and Sp1Published by Elsevier ,2002
- Limited overlapping roles of P15INK4b and P18INK4c cell cycle inhibitors in proliferation and tumorigenesisThe EMBO Journal, 2000
- Association of Stat3-Dependent Transcriptional Activation of p19INK4Dwith IL-6-Induced Growth ArrestBiochemical and Biophysical Research Communications, 1997
- Biochemical Characterization of p16 - and p18-containing Complexes in Human Cell LinesPublished by Elsevier ,1996
- Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damageCurrent Biology, 1996
- Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibitionNature, 1995
- A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigenCurrent Biology, 1995
- Cip1 blocks the initiation of DNA replication in Xenopus extracts by inhibition of cyclin-dependent kinasesPublished by Elsevier ,1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993